Score Overview
See the full market ranking โ
ENDRA Life Sciences Inc fundamental performance
Across ENDRA Life Sciences Inc's full reported history, from 2017 to 2025, revenue declined from $ 351.62K to $ 0.00 and net income went from -$ 5M to -$ 7M. Revenue increased in 0% of the years measured; net income in 50%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 4.47 | โ |
1 Year2025-08-12 | $ 4.18 | 6.94% |
5 Years2021-08-12 | $ 3.08K | -99.85% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 |
|---|---|---|---|
| Price | $ 4.47 | $ 4.18 | $ 3.08K |
| Return | โ | 6.94% | -99.85% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 7M | $ 762.37K |
| 2024 | $ 0.00 | -$ 11M | $ 3M |
| 2023 | $ 0.00 | -$ 10M | $ 2M |
| 2022 | $ 0.00 | -$ 13M | $ 4M |
| 2021 | $ 0.00 | -$ 11M | $ 9M |
| 2020 | $ 0.00 | -$ 11M | $ 7M |
| 2019 | $ 0.00 | -$ 13M | $ 6M |
| 2018 | $ 6.17K | -$ 9M | $ 6M |
| IPO2017 | $ 351.62K | -$ 5M | $ 5M |
Explore beyond NDRA
You're looking at ENDRA Life Sciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
